Current issue
Archive
About the journal
Special Issues
Abstracting and indexing
Subscription
Contact
Instructions for authors
|
4/2017
vol. 104 abstract:
Meta-analysis
Treatment of atopic dermatitis with cyclosporin A: a case reportKarolina Kaaz, Adam ReichDermatol Rev/Przegl Dermatol 2017, 104, 432-438
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction. Despite the progress that has been made in the therapy of atopic dermatitis in recent years, cyclosporin A remains the first-line treatment of severe forms of the disease.
Objective. To present a case of effective cyclosporin A therapy of severe atopic dermatitis with features of secondary bacterial infection. Case report. A 22-year-old man was admitted to hospital with extensive erythematous-desquamative skin lesions. The lesions were accompanied by intense itching. Based on the patient’s medical history, physical examination, laboratory test results and histological examination of a skin biopsy, atopic dermatitis with bacterial superinfection was diagnosed. Treatment with cyclosporin A in combination with antibiotics was initiated, resulting in significant clinical improvement within a few days after the initiation of therapy. Conclusions. Our case confirms that cyclosporin A is a fast-acting and highly effective therapeutic agent in atopic dermatitis, and the risk of adverse reactions, if the drug is used properly, is low. keywords:
atopic dermatitis, treatment, secondary infection |
FEATURED PRODUCTS
|